Horizon Therapeutics
1 Horizon Way
Deerfield
IL
60015
United States
650 articles about Horizon Therapeutics
-
Horizon Pharma plc. Reports Third Quarter 2014 Financial Results And Raises Guidance For 2014 And 2015
11/7/2014
-
Horizon Pharma plc. Appoints John J. Kody As Executive Vice President And Chief Commercial Officer
11/6/2014
-
Horizon Pharma plc. Announces DUEXIS® Selected As Winner Of Chicago Innovation Award
11/3/2014
-
Horizon Pharma plc. To Host Third Quarter 2014 Conference Call And Webcast On November 6, 2014
10/23/2014
-
Horizon Pharma plc. Reviews Future ACTIMMUNE® Opportunities At Analyst Day
10/17/2014
-
Horizon Pharma plc. Announces Presentation Of ACTIMMUNE(R) Phase 2 Data In Friedreich's Ataxia
10/9/2014
-
Horizon Pharma plc. Receives Orphan-Drug Designation For ACTIMMUNE(R) (Interferon gamma-1b) In Friedreich's Ataxia
10/6/2014
-
Horizon Pharma plc. Announces The U.S. Patent And Trademark Office Issuance Of Additional Notice Of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets
10/2/2014
-
Horizon Pharma plc. Commercial Chief Resigns; Executive Committee Formed
9/29/2014
-
Horizon Pharma plc. To Host Friedreich's Ataxia Analyst Day On October 13, 2014
9/24/2014
-
Horizon Pharma plc. To Present At The 21st Annual NewsMakers In The Biotech Industry Conference
9/23/2014
-
Horizon Pharma plc. Completes Acquisition Of Vidara Therapeutics
9/22/2014
-
Horizon Pharma plc. Moves To Ireland As Frustrated Lawmakers Look On
9/19/2014
-
Horizon Pharma plc. Announces Board Of Directors Following Closing Of Acquisition Of Vidara Therapeutics International plc
9/19/2014
-
Horizon Pharma Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering RAYOS(R) (Prednisone) Delayed-Release Tablets
8/27/2014
-
Horizon Pharma Reports Second Quarter 2014 Financial Results And Provides Business Update
8/8/2014
-
Horizon Pharma Announces The U.S. Patent And Trademark Office Issuance Of Additional Notices Of Allowance With Claims Covering VIMOVO®(Naproxen / Esomeprazole) Delayed Release Tablets
8/6/2014
-
Horizon Pharma To Host Conference Call And Webcast To Discuss Second Quarter 2014 Financial Results On August 7, 2014
7/30/2014
-
Horizon Pharma Announces Robert J. De Vaere To Retire And Names Paul W. Hoelscher Chief Financial Officer
6/18/2014
-
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
6/9/2014